Investors focus on how Pfizer will spend COVID-19 windfall: GS

Pharmaceutical company Pfizer is carefully calculating its next move following the windfall it experienced during the COVID-19 pandemic. Yahoo Finance Healthcare Reporter Anjalee Khemlani highlights Pfizer CEO Albert Bourla's comments on Pfizer's stock outlook and plans to return capital to investors.